MUMBAI (Reuters) - Drugmaker Wockhardt Ltd (WCKH.NS) is recalling 109,744 bottles of a high blood pressure drug in the United States after it failed a dissolution test, the U.S. Food and Drug ...

Wockhardt files for European marketing approval of WCK 5222, a novel antibiotic targeting multi-drug resistant infections.

The EMA is the regulatory authority responsible for the scientific evaluation, of new medicines across the 27 European Union (EU) Member States and three European Economic Area (EEA) countriesIceland, ...

Mumbai: Wockhardt has announced that it has been informed by the European Medicines Agency (EMA) that WCK 5222, a combination ...

Wockhardt Ltd is quoting at Rs 1513.7, up 3.27% on the day as on 12:49 IST on the NSE. The stock is up 3.84% in last one year as compared to a 10.1% jump in NIFTY and a 0.64% jump in the Nifty Pharma ...

India’s Wockhardt, which has had its financial fortunes dampened for several years by FDA-related manufacturing issues, has decided to improve its cash flow by selling a plant and portfolio of ...

If you want to know who really controls Wockhardt Limited (NSE:WOCKPHARMA), then you’ll have to look at the makeup of its share registry. Insiders often own a large chunk of younger, smaller, ...

Wockhardt Bio AG and Jemincare have partnered for Wockhardt’s novel patented antibiotic WCK 4873 (INN: Nafithromycin) in People’s Republic of China, Hong Kong, Macau and Taiwan for the treatment of ...

Shares of drug firm Wockhardt are in action even as the benchmark indices declined in early trade on Tuesday, December 2, 2025, amid uncertainty over repo rate cuts. The counter opened in green at Rs ...

In the summer of 2013, Wockhardt Chairman Habil Khorakiwala had finally begun to breathe easy after five years of losses, asset sales, court cases and corporate-debt restructuring. During an ...

The company has received the coveted status from the US Food and Drug Administration (USFDA) for 'WCK 5222', a product from its new drug discovery programme in anti-infectives, Wockhardt said in a ...

It becomes apparent within 10 minutes of speaking with Zahabiya Khorakiwala, Managing Director of Wockhardt Hospitals, that she is being very careful of what she says. Every time she is asked a ...